Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
1500 26 30 26 30 B-lower_bound
/ 30 31 30 31 I-lower_bound
ul 31 33 31 33 I-lower_bound
or 34 36 34 36 O
more 37 41 37 41 O

Any 0 3 42 45 O
diagnosis 4 13 46 55 O
of 14 16 56 58 O
immunodeficiency 17 33 59 75 B-chronic_disease
or 34 36 76 78 O
current 37 44 79 86 B-treatment
immunosuppressive 45 62 87 104 I-treatment
therapy 63 70 105 112 I-treatment
including 71 80 113 122 O
> 81 82 123 124 O
10mg 82 86 124 128 B-lower_bound
/ 86 87 128 129 I-lower_bound
day 87 90 129 132 I-lower_bound
of 91 93 133 135 O
prednisone 94 104 136 146 B-treatment
within 105 111 147 153 O
14 112 114 154 156 B-upper_bound
days 115 119 157 161 I-upper_bound
of 120 122 162 164 O
enrollment 123 133 165 175 O
is 134 136 176 178 O
not 137 140 179 182 O
permitted 141 150 183 192 O

Any 0 3 193 196 O
prior 4 9 197 202 O
chemotherapy 10 22 203 215 B-treatment
or 23 25 216 218 O
radiation 26 35 219 228 B-treatment
therapy 36 43 229 236 I-treatment
for 44 47 237 240 O
the 48 51 241 244 O
current 52 59 245 252 O
diagnosis 60 69 253 262 O

Any 0 3 263 266 O
prior 4 9 267 272 B-treatment
radiotherapy 10 22 273 285 I-treatment
to 23 25 286 288 O
the 26 29 289 292 O
neck 30 34 293 297 O

Any 0 3 298 301 O
prior 4 9 302 307 B-treatment
therapy 10 17 308 315 I-treatment
with 18 22 316 320 O
anti 23 27 321 325 B-treatment
- 27 28 325 326 I-treatment
PD-1 28 32 326 330 I-treatment
, 32 33 330 331 O
anti 34 38 332 336 B-treatment
- 38 39 336 337 I-treatment
PD 39 41 337 339 I-treatment
- 41 42 339 340 I-treatment
L2 42 44 340 342 I-treatment
, 44 45 342 343 O
anti 46 50 344 348 B-treatment
- 50 51 348 349 I-treatment
CTLA-4 51 57 349 355 I-treatment
antibody 58 66 356 364 I-treatment
, 66 67 364 365 O
or 68 70 366 368 O
any 71 74 369 372 O
other 75 80 373 378 O
antibody 81 89 379 387 O
or 90 92 388 390 O
drug 93 97 391 395 O
specifically 98 110 396 408 O
targeting 111 120 409 418 O
T 121 122 419 420 O
- 122 123 420 421 O
cell 123 127 421 425 O
co 128 130 426 428 O
- 130 131 428 429 O
stimulation 131 142 429 440 O
or 143 145 441 443 O
immune 146 152 444 450 O
checkpoint 153 163 451 461 O
pathways 164 172 462 470 O

Bilirubin 0 9 471 480 B-clinical_variable
less 10 14 481 485 O
than 15 19 486 490 O
or 20 22 491 493 O
equal 23 28 494 499 O
to 29 31 500 502 O
1.5 32 35 503 506 B-upper_bound
x 36 37 507 508 I-upper_bound
the 38 41 509 512 I-upper_bound
upper 42 47 513 518 I-upper_bound
limit 48 53 519 524 I-upper_bound
of 54 56 525 527 I-upper_bound
normal 57 63 528 534 I-upper_bound
( 64 65 535 536 O
except 65 71 536 542 O
subjects 72 80 543 551 O
with 81 85 552 556 O
Gilbert 86 93 557 564 B-chronic_disease
syndrome 94 102 565 573 I-chronic_disease
, 102 103 573 574 O
who 104 107 575 578 O
can 108 111 579 582 O
have 112 116 583 587 O
total 117 122 588 593 O
bilirubin 123 132 594 603 B-clinical_variable
< 133 134 604 605 O
3 135 136 606 607 B-upper_bound
mg 137 139 608 610 I-upper_bound
/ 139 140 610 611 I-upper_bound
dl 140 142 611 613 I-upper_bound
) 142 143 613 614 O

Eastern 0 7 615 622 B-clinical_variable
Cooperative 8 19 623 634 I-clinical_variable
Oncology 20 28 635 643 I-clinical_variable
Group 29 34 644 649 I-clinical_variable
( 35 36 650 651 I-clinical_variable
ECOG 36 40 651 655 I-clinical_variable
) 40 41 655 656 I-clinical_variable
performance 42 53 657 668 I-clinical_variable
status 54 60 669 675 I-clinical_variable
0 61 62 676 677 B-lower_bound
- 62 63 677 678 O
1 63 64 678 679 B-upper_bound

Hemoglobin 0 10 680 690 B-clinical_variable
9 11 12 691 692 B-lower_bound
g 13 14 693 694 I-lower_bound
/ 14 15 694 695 I-lower_bound
dl 15 17 695 697 I-lower_bound
or 18 20 698 700 O
more 21 25 701 705 O

Inhaled 0 7 706 713 B-treatment
or 8 10 714 716 I-treatment
topical 11 18 717 724 I-treatment
steroids 19 27 725 733 I-treatment
, 27 28 733 734 O
and 29 32 735 738 O
adrenal 33 40 739 746 B-clinical_variable
replacement 41 52 747 758 I-clinical_variable
steroids 53 61 759 767 I-clinical_variable
< 62 63 768 769 O
/=10 63 67 769 773 O
mg 67 69 773 775 I-upper_bound
daily 70 75 776 781 O
prednisone 76 86 782 792 O
equivalent 87 97 793 803 O
, 97 98 803 804 O
are 99 102 805 808 O
permitted 103 112 809 818 O
in 113 115 819 821 O
the 116 119 822 825 O
absence 120 127 826 833 O
of 128 130 834 836 O
active 131 137 837 843 B-chronic_disease
autoimmune 138 148 844 854 I-chronic_disease
disease 149 156 855 862 I-chronic_disease

Men 0 3 863 866 B-gender
of 4 6 867 869 O
reproductive 7 19 870 882 O
potential 20 29 883 892 O
who 30 33 893 896 O
are 34 37 897 900 O
sexually 38 46 901 909 O
active 47 53 910 916 O
with 54 58 917 921 O
women 59 64 922 927 B-gender
of 65 67 928 930 O
reproductive 68 80 931 943 O
potential 81 90 944 953 O
must 91 95 954 958 O
use 96 99 959 962 B-contraception_consent
any 100 103 963 966 I-contraception_consent
contraceptive 104 117 967 980 I-contraception_consent
method 118 124 981 987 I-contraception_consent
with 125 129 988 992 O
a 130 131 993 994 O
failure 132 139 995 1002 O
rate 140 144 1003 1007 O
of 145 147 1008 1010 O
less 148 152 1011 1015 O
than 153 157 1016 1020 O
1 158 159 1021 1022 B-upper_bound
% 159 160 1022 1023 I-upper_bound
per 161 164 1024 1027 I-upper_bound
year 165 169 1028 1032 I-upper_bound

Oropharyngeal 0 13 1033 1046 B-cancer
primaries 14 23 1047 1056 I-cancer
that 24 28 1057 1061 O
are 29 32 1062 1065 O
HPV 33 36 1066 1069 B-cancer
- 36 37 1069 1070 I-cancer
mediated 37 45 1070 1078 I-cancer
( 46 47 1079 1080 I-cancer
p16 47 50 1080 1083 I-cancer
+ 50 51 1083 1084 I-cancer
) 51 52 1084 1085 I-cancer
must 53 57 1086 1090 O
be 58 60 1091 1093 O
stage 61 66 1094 1099 O
II 67 69 1100 1102 B-lower_bound
- 69 70 1102 1103 O
III 70 73 1103 1106 B-upper_bound

Patients 0 8 1107 1115 O
must 9 13 1116 1120 O
be 14 16 1121 1123 O
18 17 19 1124 1126 B-lower_bound
years 20 25 1127 1132 I-lower_bound
of 26 28 1133 1135 O
age 29 32 1136 1139 B-age
and 33 36 1140 1143 O
older 37 42 1144 1149 O

Patients 0 8 1150 1158 O
that 9 13 1159 1163 O
have 14 18 1164 1168 O
an 19 21 1169 1171 O
active 22 28 1172 1178 O
autoimmune 29 39 1179 1189 B-chronic_disease
disease 40 47 1190 1197 I-chronic_disease
requiring 48 57 1198 1207 O
systemic 58 66 1208 1216 B-treatment
treatment 67 76 1217 1226 I-treatment
within 77 83 1227 1233 O
the 84 87 1234 1237 O
past 88 92 1238 1242 B-upper_bound
3 93 94 1243 1244 I-upper_bound
months 95 101 1245 1251 I-upper_bound
or 102 104 1252 1254 O
a 105 106 1255 1256 O
documented 107 117 1257 1267 O
history 118 125 1268 1275 O
of 126 128 1276 1278 O
clinically 129 139 1279 1289 O
severe 140 146 1290 1296 O
autoimmune 147 157 1297 1307 O
disease 158 165 1308 1315 O

Patients 0 8 1316 1324 O
who 9 12 1325 1328 O
have 13 17 1329 1333 O
participated 18 30 1334 1346 O
in 31 33 1347 1349 O
a 34 35 1350 1351 O
study 36 41 1352 1357 O
with 42 46 1358 1362 O
an 47 49 1363 1365 O
investigational 50 65 1366 1381 O
agent 66 71 1382 1387 O
or 72 74 1388 1390 O
device 75 81 1391 1397 O
within 82 88 1398 1404 O
2 89 90 1405 1406 B-upper_bound
weeks 91 96 1407 1412 I-upper_bound
of 97 99 1413 1415 O
initiation 100 110 1416 1426 O
of 111 113 1427 1429 O
treatment 114 123 1430 1439 O

Patients 0 8 1440 1448 O
with 9 13 1449 1453 O
a 14 15 1454 1455 O
known 16 21 1456 1461 O
human 22 27 1462 1467 B-chronic_disease
immunodeficiency 28 44 1468 1484 I-chronic_disease
virus 45 50 1485 1490 I-chronic_disease
infection 51 60 1491 1500 I-chronic_disease
( 61 62 1501 1502 I-chronic_disease
HIV 62 65 1502 1505 I-chronic_disease
1/2 66 69 1506 1509 I-chronic_disease
antibodies 70 80 1510 1520 I-chronic_disease
) 80 81 1520 1521 I-chronic_disease
or 82 84 1522 1524 O
acquired 85 93 1525 1533 B-chronic_disease
immunodeficiency 94 110 1534 1550 I-chronic_disease
syndrome 111 119 1551 1559 I-chronic_disease
( 120 121 1560 1561 I-chronic_disease
HIV 121 124 1561 1564 I-chronic_disease
/ 124 125 1564 1565 I-chronic_disease
AIDS 125 129 1565 1569 I-chronic_disease
) 129 130 1569 1570 I-chronic_disease

Patients 0 8 1571 1579 O
with 9 13 1580 1584 O
evidence 14 22 1585 1593 O
of 23 25 1594 1596 O
interstitial 26 38 1597 1609 B-chronic_disease
lung 39 43 1610 1614 I-chronic_disease
disease 44 51 1615 1622 I-chronic_disease
or 52 54 1623 1625 O
active 55 61 1626 1632 O
, 61 62 1632 1633 O
non 63 66 1634 1637 B-chronic_disease
- 66 67 1637 1638 I-chronic_disease
infectious 67 77 1638 1648 I-chronic_disease
pneumonitis 78 89 1649 1660 I-chronic_disease

Patients 0 8 1661 1669 O
with 9 13 1670 1674 O
uncontrolled 14 26 1675 1687 O
intercurrent 27 39 1688 1700 B-chronic_disease
illnesses 40 49 1701 1710 I-chronic_disease
including 50 59 1711 1720 O
, 59 60 1720 1721 O
but 61 64 1722 1725 O
not 65 68 1726 1729 O
limited 69 76 1730 1737 O
to 77 79 1738 1740 O
an 80 82 1741 1743 O
active 83 89 1744 1750 B-chronic_disease
infection 90 99 1751 1760 I-chronic_disease
requiring 100 109 1761 1770 O
systemic 110 118 1771 1779 B-treatment
therapy 119 126 1780 1787 I-treatment
or 127 129 1788 1790 O
a 130 131 1791 1792 O
known 132 137 1793 1798 O
psychiatric 138 149 1799 1810 B-chronic_disease
or 150 152 1811 1813 O
substance 153 162 1814 1823 B-chronic_disease
abuse 163 168 1824 1829 I-chronic_disease
disorder(s 169 179 1830 1840 I-chronic_disease
) 179 180 1840 1841 I-chronic_disease
that 181 185 1842 1846 O
would 186 191 1847 1852 O
interfere 192 201 1853 1862 O
with 202 206 1863 1867 O
cooperation 207 218 1868 1879 O
with 219 223 1880 1884 O
the 224 227 1885 1888 O
requirements 228 240 1889 1901 O
of 241 243 1902 1904 O
the 244 247 1905 1908 O
trial 248 253 1909 1914 O

Platelets 0 9 1915 1924 B-clinical_variable
100,000 10 17 1925 1932 B-lower_bound
/ 17 18 1932 1933 I-lower_bound
ul 18 20 1933 1935 I-lower_bound
or 21 23 1936 1938 O
more 24 28 1939 1943 O

Tumor 0 5 1944 1949 B-cancer
sample 6 12 1950 1956 O
must 13 17 1957 1961 O
be 18 20 1962 1964 O
available 21 30 1965 1974 O
for 31 34 1975 1978 O
HPV 35 38 1979 1982 B-cancer
p16 39 42 1983 1986 I-cancer
and 43 46 1987 1990 O
PD 47 49 1991 1993 B-treatment
- 49 50 1993 1994 I-treatment
L1 50 52 1994 1996 I-treatment
testing 53 60 1997 2004 I-treatment

White 0 5 2005 2010 B-clinical_variable
blood 6 11 2011 2016 I-clinical_variable
cells 12 17 2017 2022 I-clinical_variable
2000 18 22 2023 2027 B-lower_bound
/ 22 23 2027 2028 I-lower_bound
ul 23 25 2028 2030 I-lower_bound
or 26 28 2031 2033 O
more 29 33 2034 2038 O

Women 0 5 2039 2044 B-gender
of 6 8 2045 2047 O
reproductive 9 21 2048 2060 O
potential 22 31 2061 2070 O
must 32 36 2071 2075 O
use 37 40 2076 2079 B-contraception_consent
highly 41 47 2080 2086 I-contraception_consent
effective 48 57 2087 2096 I-contraception_consent
contraception 58 71 2097 2110 I-contraception_consent
methods 72 79 2111 2118 I-contraception_consent
to 80 82 2119 2121 O
avoid 83 88 2122 2127 O
pregnancy 89 98 2128 2137 B-pregnancy
for 99 102 2138 2141 O
23 103 105 2142 2144 B-lower_bound
weeks 106 111 2145 2150 I-lower_bound
after 112 117 2151 2156 O
the 118 121 2157 2160 O
last 122 126 2161 2165 O
dose 127 131 2166 2170 O
of 132 134 2171 2173 O
study 135 140 2174 2179 O
drugs 141 146 2180 2185 O

Women 0 5 2186 2191 B-gender
of 6 8 2192 2194 O
reproductive 9 21 2195 2207 O
potential 22 31 2208 2217 O
should 32 38 2218 2224 O
have 39 43 2225 2229 O
a 44 45 2230 2231 O
negative 46 54 2232 2240 B-pregnancy
serum 55 60 2241 2246 I-pregnancy
or 61 63 2247 2249 I-pregnancy
urine 64 69 2250 2255 I-pregnancy
pregnancy 70 79 2256 2265 I-pregnancy
test 80 84 2266 2270 O
( 85 86 2271 2272 O
minimum 86 93 2272 2279 O
sensitivity 94 105 2280 2291 O
25 106 108 2292 2294 B-lower_bound
IU 109 111 2295 2297 I-lower_bound
/ 111 112 2297 2298 I-lower_bound
L 112 113 2298 2299 I-lower_bound
or 114 116 2300 2302 O
equivalent 117 127 2303 2313 O
units 128 133 2314 2319 O
of 134 136 2320 2322 O
human 137 142 2323 2328 B-clinical_variable
chorionic 143 152 2329 2338 I-clinical_variable
gonadotropin 153 165 2339 2351 I-clinical_variable
[ 166 167 2352 2353 I-clinical_variable
HCG 167 170 2353 2356 I-clinical_variable
] 170 171 2356 2357 I-clinical_variable
) 171 172 2357 2358 O
within 173 179 2359 2365 O
24 180 182 2366 2368 B-upper_bound
hours 183 188 2369 2374 I-upper_bound
of 189 191 2375 2377 O
the 192 195 2378 2381 O
start 196 201 2382 2387 O
of 202 204 2388 2390 O
study 205 210 2391 2396 O
drugs 211 216 2397 2402 O

active 0 6 2403 2409 O
hepatitis 7 16 2410 2419 B-chronic_disease
B 17 18 2420 2421 I-chronic_disease
( 19 20 2422 2423 O
e.g. 20 24 2423 2427 O
, 24 25 2427 2428 O
hepatitis 26 35 2429 2438 O
B 36 37 2439 2440 O
surface 38 45 2441 2448 O
antigen 46 53 2449 2456 O
[ 54 55 2457 2458 O
HBsAg 55 60 2458 2463 O
] 60 61 2463 2464 O
reactive 62 70 2465 2473 O
) 70 71 2473 2474 O

hepatitis 0 9 2475 2484 B-chronic_disease
C 10 11 2485 2486 O
( 12 13 2487 2488 O
e.g. 13 17 2488 2492 O
, 17 18 2492 2493 O
hepatitis 19 28 2494 2503 B-chronic_disease
C 29 30 2504 2505 I-chronic_disease
virus 31 36 2506 2511 I-chronic_disease
[ 37 38 2512 2513 I-chronic_disease
HCV 38 41 2513 2516 I-chronic_disease
] 41 42 2516 2517 I-chronic_disease
ribonucleic 43 54 2518 2529 B-clinical_variable
acid 55 59 2530 2534 I-clinical_variable
[ 60 61 2535 2536 I-clinical_variable
RNA 61 64 2536 2539 I-clinical_variable
] 64 65 2539 2540 I-clinical_variable
[ 66 67 2541 2542 O
qualitative 67 78 2542 2553 O
] 78 79 2553 2554 O
is 80 82 2555 2557 O
detected 83 91 2558 2566 O
) 91 92 2566 2567 O

men 0 3 2568 2571 B-gender
who 4 7 2572 2575 O
are 8 11 2576 2579 O
azoospermic 12 23 2580 2591 B-chronic_disease
do 24 26 2592 2594 O
not 27 30 2595 2598 O
require 31 38 2599 2606 O
contraception 39 52 2607 2620 O

men 0 3 2621 2624 B-gender
who 4 7 2625 2628 O
are 8 11 2629 2632 O
receiving 12 21 2633 2642 O
the 22 25 2643 2646 O
study 26 31 2647 2652 O
medications 32 43 2653 2664 O
will 44 48 2665 2669 O
be 49 51 2670 2672 O
instructed 52 62 2673 2683 O
to 63 65 2684 2686 O
adhere 66 72 2687 2693 B-contraception_consent
to 73 75 2694 2696 I-contraception_consent
contraception 76 89 2697 2710 I-contraception_consent
for 90 93 2711 2714 O
31 94 96 2715 2717 B-upper_bound
weeks 97 102 2718 2723 I-upper_bound
after 103 108 2724 2729 O
the 109 112 2730 2733 O
last 113 117 2734 2738 O
dose 118 122 2739 2743 O
of 123 125 2744 2746 O
study 126 131 2747 2752 O
drugs 132 137 2753 2758 O

menopause 0 9 2759 2768 O
is 10 12 2769 2771 O
defined 13 20 2772 2779 O
clinically 21 31 2780 2790 O
as 32 34 2791 2793 O
12 35 37 2794 2796 O
months 38 44 2797 2803 O
of 45 47 2804 2806 O
amenorrhea 48 58 2807 2817 B-chronic_disease
in 59 61 2818 2820 O
a 62 63 2821 2822 O
woman 64 69 2823 2828 B-gender
over 70 74 2829 2833 O
45 75 77 2834 2836 B-lower_bound
in 78 80 2837 2839 O
the 81 84 2840 2843 O
absence 85 92 2844 2851 O
of 93 95 2852 2854 O
other 96 101 2855 2860 O
biological 102 112 2861 2871 O
or 113 115 2872 2874 O
physiological 116 129 2875 2888 O
causes 130 136 2889 2895 O

patients 0 8 2896 2904 O
with 9 13 2905 2909 O
a 14 15 2910 2911 O
history 16 23 2912 2919 O
of 24 26 2920 2922 O
other 27 32 2923 2928 O
prior 33 38 2929 2934 O
malignancy 39 49 2935 2945 B-cancer
must 50 54 2946 2950 O
have 55 59 2951 2955 O
been 60 64 2956 2960 O
treated 65 72 2961 2968 O
with 73 77 2969 2973 O
curative 78 86 2974 2982 B-treatment
intent 87 93 2983 2989 I-treatment
and 94 97 2990 2993 O
must 98 102 2994 2998 O
have 103 107 2999 3003 O
remained 108 116 3004 3012 O
disease 117 124 3013 3020 O
- 124 125 3020 3021 O
free 125 129 3021 3025 O
for 130 133 3026 3029 O
3 134 135 3030 3031 B-upper_bound
years 136 141 3032 3037 I-upper_bound
post 142 146 3038 3042 O
- 146 147 3042 3043 O
diagnosis 147 156 3043 3052 O

squamous 0 8 3053 3061 B-cancer
cell 9 13 3062 3066 I-cancer
carcinoma 14 23 3067 3076 I-cancer
of 24 26 3077 3079 O
the 27 30 3080 3083 O
skin 31 35 3084 3088 O

subjects 0 8 3089 3097 O
with 9 13 3098 3102 O
vitiligo 14 22 3103 3111 B-chronic_disease
, 22 23 3111 3112 O
type 24 28 3113 3117 B-chronic_disease
I 29 30 3118 3119 I-chronic_disease
diabetes 31 39 3120 3128 I-chronic_disease
mellitus 40 48 3129 3137 I-chronic_disease
, 48 49 3137 3138 O
or 50 52 3139 3141 O
resolved 53 61 3142 3150 O
childhood 62 71 3151 3160 O
asthma 72 78 3161 3167 B-chronic_disease
/ 78 79 3167 3168 O
atopy 79 84 3168 3173 B-chronic_disease
would 85 90 3174 3179 O
be 91 93 3180 3182 O
an 94 96 3183 3185 O
exception 97 106 3186 3195 O
to 107 109 3196 3198 O
this 110 114 3199 3203 O
rule 115 119 3204 3208 O

superficial 0 11 3209 3220 B-cancer
bladder 12 19 3221 3228 I-cancer
cancer 20 26 3229 3235 I-cancer
or 27 29 3236 3238 O
in 30 32 3239 3241 B-cancer
situ 33 37 3242 3246 I-cancer
cervical 38 46 3247 3255 I-cancer
cancer 47 53 3256 3262 I-cancer
that 54 58 3263 3267 O
has 59 62 3268 3271 O
undergone 63 72 3272 3281 O
potentially 73 84 3282 3293 O
curative 85 93 3294 3302 B-treatment
therapy 94 101 3303 3310 I-treatment

syndrome 0 8 3311 3319 O
that 9 13 3320 3324 O
requires 14 22 3325 3333 O
systemic 23 31 3334 3342 B-treatment
steroids 32 40 3343 3351 I-treatment
( 41 42 3352 3353 O
> 42 43 3353 3354 O
10 44 46 3355 3357 B-lower_bound
mg 47 49 3358 3360 I-lower_bound
daily 50 55 3361 3366 O
prednisone 56 66 3367 3377 B-treatment
equivalents 67 78 3378 3389 O
) 78 79 3389 3390 O
or 80 82 3391 3393 O
immunosuppressive 83 100 3394 3411 B-treatment
agents 101 107 3412 3418 I-treatment

women 0 5 3419 3424 B-gender
of 6 8 3425 3427 O
reproductive 9 21 3428 3440 O
potential 22 31 3441 3450 O
is 32 34 3451 3453 O
defined 35 42 3454 3461 O
as 43 45 3462 3464 O
any 46 49 3465 3468 O
female 50 56 3469 3475 B-gender
who 57 60 3476 3479 O
has 61 64 3480 3483 O
experienced 65 76 3484 3495 O
menarche 77 85 3496 3504 O
and 86 89 3505 3508 O
who 90 93 3509 3512 O
has 94 97 3513 3516 O
not 98 101 3517 3520 O
undergone 102 111 3521 3530 O
surgical 112 120 3531 3539 O
sterilization 121 134 3540 3553 O
( 135 136 3554 3555 O
hysterectomy 136 148 3555 3567 B-treatment
or 149 151 3568 3570 O
bilateral 152 161 3571 3580 B-treatment
oophorectomy 162 174 3581 3593 I-treatment
) 174 175 3593 3594 O
or 176 178 3595 3597 O
who 179 182 3598 3601 O
is 183 185 3602 3604 O
not 186 189 3605 3608 O
postmenopausal 190 204 3609 3623 O

women 0 5 3624 3629 B-gender
under 6 11 3630 3635 O
the 12 15 3636 3639 O
age 16 19 3640 3643 B-age
of 20 22 3644 3646 O
55 23 25 3647 3649 B-upper_bound
must 26 30 3650 3654 O
have 31 35 3655 3659 O
a 36 37 3660 3661 O
documented 38 48 3662 3672 O
serum 49 54 3673 3678 B-clinical_variable
follicle 55 63 3679 3687 I-clinical_variable
stimulating 64 75 3688 3699 I-clinical_variable
hormone 76 83 3700 3707 I-clinical_variable
( 84 85 3708 3709 I-clinical_variable
FSH 85 88 3709 3712 I-clinical_variable
) 88 89 3712 3713 I-clinical_variable
level 90 95 3714 3719 I-clinical_variable
more 96 100 3720 3724 O
than 101 105 3725 3729 O
40 106 108 3730 3732 B-lower_bound
mIU 109 112 3733 3736 I-lower_bound
/ 112 113 3736 3737 I-lower_bound
mL 113 115 3737 3739 I-lower_bound

